Skip to content

    Recently Viewed

      Listening...

      Johnson & Johnson to Participate in the Leerink Global Biopharma Conference

      Share Article
      share to

      New Brunswick, N.J., February 12th, 2024 Johnson & Johnson (NYSE: JNJ) will participate in the Leerink Global Biopharma Conference on Tuesday, March 12th, at the Fontainebleau Miami Beach, FL. Joe Wolk, Executive Vice President, Chief Financial Officer will represent the Company in a session scheduled at 1:00 p.m. (Eastern Time).

      This live audio webcast will be available to investors and other interested parties by accessing the Johnson & Johnson website at www.investor.jnj.com.

      The audio webcast replay will be available approximately 48-hrs after the webcast.

      Media contact:
      media-relations@its.jnj.com

      Investor contact:
      investor-relations@its.jnj.com

      You are now leaving jnj.com. The site you’re being redirected to is a branded pharmaceutical website. Please click below to continue to that site.